<DOC>
	<DOCNO>NCT02369861</DOCNO>
	<brief_summary>Subjects moderate-to-severe Dry Eye symptom screen include history , ophthalmic examination include status ocular structure function evaluation tear production . Blood blood drawn complete blood count chemistry panel . They also urinalysis pregnancy test woman child-bearing potential . Subjects two week `` run-in '' period use artificial tear . If Dry Eye sign symptom improve significantly , enrol receive study drug . Safety evaluation include assessment structure function eye include retina examination correct visual acuity . Subjects meet inclusion exclusion criterion randomly assign one two treatment arm , ACCS `` artificial tear '' eye drop . The randomization scheme 1:1 ACCS : artificial tear . Subjects self-administer eye drop four time day . Subjects see office ophthalmologist/optometrist baseline ( week zero ) , one week , three week , six week ten week . Eye examination do visit . The baseline eye test lab work repeat treatment phase study end week six . Following 6 week treatment , subject follow 4 additional week .</brief_summary>
	<brief_title>Study ACCS Eye Drops Treating Dry Eye</brief_title>
	<detailed_description>Subjects moderate-to-severe Dry Eye judge symptom screen follow signing informed consent . Screening involve history physical examination include ophthalmic examination dilate fundus exam ass status ocular structure function , evaluation tear production damage cause clinically significant Dry Eye . Blood blood drawn complete blood count , chemistry panel include serum glucose , blood urea nitrogen , electrolytes , creatinine , liver function study include total direct bilirubin , alkaline phosphatase , alanine transaminase ( ALT ) , aspartate transaminase ( AST ) , albumin , total protein . They also urinalysis . Pregnancy test perform woman child-bearing potential . Subjects two week `` run-in '' period use artificial tear . Those subject corneal stain 2 ( scale 0-4 ) , Dry Eye symptom score OSDI 25-75 two week use artificial tear four time per day , laboratory test result within accepted range enrol receive study drug , Those subject dry eye symptom improve sufficiently ( OSDI drop 25 ) and/or corneal stain reduce 2 less 2 , laboratory test result outside accepted range enrol . Safety evaluation include assessment structure function eye include conjunctival corneal tissue . Corrected visual acuity measure every visit . Patient comfort assess administration study drug every visit . A retina examination perform treatment period . Slit lamp exam include cornea , conjunctiva , anterior chamber , iris , eye lid lash perform every visit . Special test include fluorescein stain cornea , lissamine green stain conjunctiva , endothelial cell analysis , Schirmer tear production , intraocular pressure measure subject . Subjects meet inclusion exclusion criterion randomly assign one two treatment arm , ACCS `` artificial tear '' eye drop . ACCS artificial tear eye drop supply Stemnion , personnel subject train use . The treatment prepare coded container subject physician mask treatment . One treatment arm receive ACCS eye drop eye treatment arm receive artificial tear eye drop eye . Treatment arm assign random . The randomization scheme 1:1 ACCS : artificial tear . Subjects self-administer eye drop four time day . Subjects ask keep study diary place study medication eye . Subjects see office ophthalmologist/optometrist baseline ( week zero ) , one week , three week , six week ten week . Eye examination do visit . Each subject complete patient questionnaire symptom Dry Eye . The baseline eye test lab work repeat treatment phase study end week six . Following 6 week treatment , subject follow 4 additional week .</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<criteria>1 . Subjects age 18 year old . 2 . Subjects symptoms sign Dry Eye &gt; four month support previous clinical diagnosis selfreported history . 3 . Visual acuity correct 20/40 good eye . 4 . If wearing contact lens , subject must willing refrain wear contact lens study ( include washout period ) . 5 . Score 2575 Ocular Surface Disorder Index ( OSDI ) questionnaire . 6 . Corneal stain grade 2 anywhere cornea ( scale 04 ) . 1 . Pregnant breast feeding . 2 . Anterior segment disease Dry Eye opinion investigator would confound study . 3 . Macular neovascular eye diseases 4 . History corneal surgery LASIK ( laser situ keratomileusis ) surgery either eye within past year . 5 . Use cyclosporine , steroid eye drop , serum eye drop , eye medication ( except artificial tear ) experimental drug within past 30 day . 6 . Subjects glaucoma glaucoma suspect . 7 . Use anticholinergic drug , antihistamine , betablockers , tricyclic antidepressant within past 30 day . 8 . Asymmetric punctal plug punctal cauterization within past three month . 9 . History StevensJohnson disease , ocular cicatricial pemphigoid , alkali burn eye , graftversushost disease . 10 . Immune compromise reason . 11 . Kidney liver function study &gt; 2x upper limit normal . 12 . Symptomatic abnormality od lid . 13 . History cancer within past 5 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>